Clinical Trials Related to Cervical Cancers

Related studies linked through entity extraction aliases.

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Status: COMPLETED
Phase: PHASE1

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Status: COMPLETED
Phase: PHASE3

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Status: COMPLETED
Phase: PHASE3

A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)

Status: COMPLETED
Phase: PHASE3

Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

Status: COMPLETED
Phase: PHASE2